<xmp id="yyses">
<xmp id="yyses"><nav id="yyses"></nav>
<center id="yyses"><wbr id="yyses"></wbr></center>
  • <nav id="yyses"></nav>
    <dd id="yyses"></dd>
  • P

    roductsand services

    Innovative Drugs

    Home > Products & services > Innovative Drugs

    SPN003 / SPN004

    Candidate drug screening is going to be completed.

    SPN003/SPN004 are  innovative peptide drugs with synergistic effect on target,  with metabolic diseases including type 2 diabetes and obesity as the main indications.

    SPN007

    Candidate drug screening  has been completed, preclinical studies  are under way.

    SPN007 is a new polypeptide drug with proprietary intellectual property rights. Its indications have expanded from simply lowering blood glucose levels in type 2 diabetes to treating obesity and non-alcoholic fatty liver disease (NASH).

    SPN009

    At the stage of preclinical studies.

    Spn009 is an innovative long-acting hypoglycemic drug  for type 2 diabetes mellitus.

    SPN-X

    At the stage of candidate drug screening.

    SPN-X is a peptide inhibitor against the novel coronavirus main protease.

    Mobile version

    Contact

    Sales Department:
    +86-571-88671330
    +86-571-88671216

    快三分分彩 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>